PATENT CLAIM ANALYSIS

Application Number: 15743764
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "136100"]

Abstract:
The present disclosure relates to antibody molecules comprising a binding domain specific to CD79, said binding domain comprising SEQ ID NO: 1, 2, 3 or 4, and/or SEQ ID NO: 5, 6 and 7. The disclosure also extends to pharmaceutical compositions comprising said antibody molecules and use of the antibody molecules/compositions in treatment.

Claim (Index 21):
The antibody molecule according to  claim 17  comprising one binding domain which is specific to CD79 and one binding domain which is specific to CD22 or CD45.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 86.0
- Lexical Diversity: 1.55
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15743756', '15326501', '15311198', '14960015', '15087405']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7881881111934357
- 35 USC 102 Novelty (BERT): 0.6327312634767703
- Combined Prediction Score: 0.7726424264217692
- Mean Citation Score: 484.271568
- Max Citation Score: 683.33405
- Similarity Product: 536.6204485589982

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test